Indefinite Delivery Contract 36C26126D0003

Award Date 10/1/25
Last Date to Order 9/30/30
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $5,000,000.00 and a period of performance through September 30, 2028. Under this IDC, Cepheid is providing its molecular testing products, including the GeneXpert diagnostic system and associated reagents, test kits, and consumables, to...
This federal Indefinite Delivery Contract (IDC) with a ceiling value of $49,000,000 was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract enables the continuous procurement of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support clinical testing programs across various federal agencies, including the Department of Veterans Affairs...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) granted by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $1,434,421.04 contract is for the lease and supply of GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs serving veterans. The contract does not have a set-aside designation....
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including the GeneXpert testing platform. The single-award IDC, valued up to $1,500,000, is for the procurement of GeneXpert test kits, reagents, and associated maintenance and support services. This IDC enables the VA to continuously acquire Cepheid's molecular diagnostic products and...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20, a civilian agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $2,200,000 and a period of performance ending on August 31, 2029. Under this single-award IDC, Cepheid will provide the VA with reagents and consumables for laboratory tests. The contract includes a specific Firm Fixed Price...
This Indefinite Delivery Contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $1,000,000.00 and a period of performance from January 1, 2024 to March 31, 2026. The contract is for the provision of CEPHEID GENEXPERT INFINITY MOLECULAR REAGENTS to support clinical testing programs for veterans. Two task orders have been issued under this IDC,...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 and Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $3,426,923.40 and a period of performance extending to June 30, 2029. Under this IDC, Cepheid will provide the VA with a reagent lease for its molecular diagnostic testing equipment and associated...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The IDV, valued at up to $3,000,000, is for the procurement of Cepheid's XPERT MRSA, FLU, and COVID-19 test kits compatible with the VA's existing GeneXpert analyzers. The contract has no set-aside designation and is a single award. Delivery orders have been issued...
The Department of Veterans Affairs (VA) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, an Indefinite Delivery Contract (IDC) to provide reagents, test kits, and associated maintenance and support services to support the VA's clinical testing programs serving veterans. The contract, valued at up to $532,310.79, is a single-award IDC with the VA's Veterans Integrated Service Network 16 and does not have any set-aside designations. Under this IDC, the VA has...
This federal contract IDV award from the Department of Veterans Affairs (VA) is to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The IDV has a ceiling value of $7,489,000.00 and an ultimate completion date of September 30, 2029. Under this IDV, Cepheid provides the VA with its GeneXpert diagnostic equipment, reagents, test kits, and associated maintenance and support services to support clinical testing programs for veterans. The contract is not set-aside and is a...
  • 36C26126D0003
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21, a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the supply of the Cepheid GeneXpert Molecular Diagnostic Testing System and associated services, with a ceiling value of $416,419.51 and a period of performance through September 30, 2026. This contract is not designated as a set-aside.

The original solicitation was a Sources Sought notice, where the VA was conducting market research to identify potential vendors for the Cepheid GeneXpert Molecular Diagnostic Testing System supplies and services. The procurement focuses on obtaining PCR testing equipment and related services for diagnosing multiple medical conditions, including COVID-19, Influenza, RSV, C-Diff, Women's Health infections, and Tuberculosis. The anticipated annual requirement is approximately 100-450 test kits across various diagnostic categories. This is a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract covering five ordering periods from October 1, 2025, through September 30, 2030, with no specific set-aside designation.

Generated 10/2/25, 11:02 AM